St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
Familial adenomatous polyposis (FAP) is a genetic condition that causes growths in the large and small intestines. The growths are called polyps. If polyps are not removed, they can become cancerous over time. People with FAP have a high risk of developing polyps and colon cancer, as well as other digestive system cancers at a young age.
People with FAP also have a higher risk of developing other tumors or cancers. They may have other symptoms or conditions as well.
Familial adenomatous polyposis is hereditary, which means it can be passed from parents to their children.
There are 4 subtypes of FAP:
The major cancer risk in FAP is cancer in the large and small intestines. For people with classic FAP, Gardner syndrome, and Turcot syndrome, polyps in the colon often start appearing around age 16. They can appear as early as 7 years of age or as late as 35.
By age 35, about 95% of people with these conditions have developed polyps in the colon. Without surgery to remove the colon, people with these types of FAP will all eventually develop colon cancer. The average age of colon cancer in people with FAP who have not had their colon removed is 39.
Cancer type | Lifetime chance |
---|---|
Colon cancer (if colon is not removed) | 70–100% |
Small intestines | 4–12% |
Thyroid cancer | 1–12% |
Hepatoblastoma (childhood liver cancer) | Less than 2% |
Medulloblastoma (childhood brain cancer) | Less than 1% |
Pancreatic cancer | Less than 1% |
Stomach cancer | Less than 1% |
Bile duct cancer (cancer of the tubes that drain bile from the liver into the gallbladder) | Less than 1% |
Up to 1 in 8 people with classic FAP, Gardner syndrome, and Turcot syndrome are also at risk for small intestine cancer. Small intestine cancer usually occurs after age 17. The average age of diagnosis is 45–52 years.
People with attenuated FAP have a slightly lower risk of colon cancer compared to classic FAP. For those with this subtype who have not had their colon removed, the average age of colon cancer diagnosis is 50–55.
Other features of FAP include:
Genes carry information telling cells in the body how to function. FAP is caused by changes in the gene APC. This gene helps control how cells grow and divide.
Most people without FAP carry 2 working copies of the APC gene in their cells. One copy is from their mother. Another copy is from their father. Cells from people with FAP carry 1 working copy of APC and 1 copy that is changed. This change causes the gene to not work right. It is called an APC mutation.
Most children with FAP inherit the APC gene mutation from a parent who also has FAP. About 20–25% of people with FAP have a new APC mutation that did not come from a parent. These children have no history of FAP in their family. In these cases, the change happened in either an egg or a sperm or in a cell of the developing embryo. These children are the first in their families to have FAP.
No matter how the APC gene changed, people with FAP have up to a 50% (1 in 2) chance of passing it on to their children.
As people with FAP get older, the remaining working copy of APC often changes within some of their cells. When both copies of the gene change, polyps and eventually cancer can develop. That is why people with FAP have a higher risk of developing cancer than people who do not have FAP.
Learn more about genetic counselors and understanding genetic risk.
A health care provider may suspect that your child has FAP after studying their medical and family cancer history.
This information helps the health care provider and the genetic counselor know if:
Your provider or genetics counselor may recommend genetic testing if they suspect FAP.
Learn more about types of genetic tests.
A blood sample is sent to a genetic testing lab. The lab runs genetic tests that looks for changes in the APC gene.
If your child has an APC mutation, the genetic counselor will work with your family to:
Parents may choose to do prenatal testing to find out if a pregnancy is affected with a known APC mutation. Testing may take place either before pregnancy occurs or during pregnancy.
You should work with a genetic counselor to review the pros and cons of the test. The genetic counselor can also help you prepare for the test results.
Testing before pregnancy is called preimplantation genetic testing (PGT). This special type of genetic testing is done along with in vitro fertilization (IVF). PGT tests embryos for a known APC mutation before a provider places them into the uterus.
Testing during pregnancy can help providers see if a pregnancy is affected with a known APC mutation. A provider gathers cells from the pregnancy in 1 of 2 ways:
After tissue collection, the lab checks the sample for the APC mutation. Both tests carry minor risks. Discuss these risks with an experienced health care provider or a genetic counselor.
Take time to think carefully about the benefits and risks of genetic testing. Speak with a genetic counselor before testing. If you decide to get tested, talk with your health care provider or a genetic counselor about your results so you can understand what they mean.
Sometimes, children or adults with FAP feel sad, anxious or angry after getting their test results. Parents may feel guilty if they pass the APC gene mutation to 1 or more of their children. People with an APC gene mutation may also have trouble getting disability or life insurance.
Read more about genetic discrimination.
To manage FAP, it is important to get regular screening for polyps. If polyps are found, they are removed. If there are many polyps, the colon may eventually be removed. The goal of screening is to find and treat growths such as polyps or other tumors early for the best outcome.
Screenings for attenuated FAP are different than for other forms of FAP. Recommended screenings may change over time as doctors learn more about FAP and all of the subtypes. Talk about all screening options with your care team. Because FAP is a complex condition, seek out an experienced doctor for your child.
People of any age with FAP have a higher risk of cancer. It is important to monitor children’s health and help them adopt healthy habits. They need to have regular physical checkups and screenings. That way, the care team can find cancer early at the most treatable stage.
People with FAP should watch for signs or symptoms that could signal cancer, such as:
It is important to seek medical help if anything unusual appears.
Habits that will help you maintain a healthy lifestyle include:
The St. Jude Cancer Predisposition Program is dedicated to diagnosing and screening children with a genetic predisposition for cancer. Our program offers the best clinical care possible. We engage in cutting-edge research to gain more information about genetic disorders and cancer, and to improve the care and treatment for patients who are affected by these conditions. Learn more about the Division of Cancer Predisposition at St. Jude.
Our genetic counselors, clinicians, genetics nurse practitioners, and research assistants work together to provide patients with:
FAP increases your child’s risk for many types of cancer.
St. Jude offers clinical trials and cancer research studies for children, teens, and young adults who have cancers associated with FAP. See diseases treated at St. Jude.
Learn more about clinical research at St. Jude.
Study goal:
To learn more about participants beliefs, attitudes, and questions about gene therapy to help make web-based resources to share information. This could help patients make treatment decisions.
Age:
18 to 35 years old with rare genetic diseases
Study goal:
The main goal of this study is to learn more about the reasons childhood tumors form and how to treat them better.
Study goal:
To provide a high-quality repository of tumor and normal samples to facilitate translational research performed by St Jude faculty and their collaborators
Study goal:
1) Test each patient for hundreds of gene variations that might be important for drug use. All of the gene test results will be in the research laboratory, but as time goes on, the study will evaluate scientific evidence and selectively move test results for a few genes into the medical record if the evidence strongly shows that the result can help in better prescribing of drugs for patients; 2) Estimate how often pharmacogenetic test results are moved from research tests into a patient’s medical record; 3) Use methods to choose which of these tests should be put in the medical record; 4) Use computer-based tools in the electronic medical record to help doctors use gene test results when prescribing drugs; 5) Share feelings and concerns of patients and their families about gene test information being put in their medical record.
Study goal:
The main purpose of this trial is to learn about the genetic causes of cancer.
Age:
Younger than 50 years old
Study goal:
To collect data about how Friedreich’s ataxia progresses over time and affects the daily life of patients.
Age:
Any
Patients accepted to St. Jude must have a disease we treat and must be referred by a physician or other qualified medical professional. We accept most patients based on their ability to enroll in an open clinical trial.
Call: 1-888-226-4343 (toll-free) or 901-595-4055 (local) | Fax: 901-595-4011 | Email: referralinfo@stjude.org | 24-hour pager: 1-800-349-4334
If you have questions about the Genetic Predisposition Clinic and care for FAP, email our team at GPTeam@stjude.org.